A Microneurography (MNG) Study of VX-150 in Healthy Participants
Clinical trial NCT05418712 · COMPLETED
Trial details
- NCT number
- NCT05418712
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-16
- Primary completion
- 2022-09-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.